IL6 and atherosclerosis: Moreover, aberrant signaling via non-mutated JAKs downstream of the IL1B/IL6 signaling axis has been identified as the key driver of vascular disease associated with more frequent drivers of CHIP like mutant TET2 and IL6 blockade allowing mitigation of atherosclerosis [266, 267].